Exo, a Redwood City CA-based health information and devices company, raised $220M in Series C funding.
The round was led by RA Capital Management with participation from BlackRock, Sands Capital, Avidity Partners and Pura Vida Investments.
The company intends to use the funds to accelerate growth, expand operations and its business reach.
Led by CEO Sandeep Akkaraju, Exo leverages ultrasound silicon technology to advance a handheld ultrasound device that will, once regulatory approvals have been obtained, use new materials, processes and AI to generate high quality medical imaging for the entire body at an affordable cost. The company’s medical imaging ecosystem includes its proprietary point-of-care ultrasound workflow solution, Exo Works. The software works with nearly all point-of-care ultrasound devices and securely connects to the most common EMR and PACS systems used in hospitals to house imaging and communications.
FinSMEs
29/07/2021